Veronica Chollette

Veronica Chollette

Auto-generated profile, based on publicly available information

Veronica Chollette

Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Health Services Research
Verified
Journal Article
Closed access
JSJaneth I. Sanchez
Janeth I. Sanchez
MDMichelle Doose
Michelle Doose
CZChris Zeruto
Chris Zeruto
VCVeronica Chollette
Veronica Chollette
NGNatalie Gasca
Natalie Gasca
SWSallie J. Weaver
Sallie J. Weaver

1 January 2023 in JCO Oncology Practice
Verified
Journal Article
Closed access
MDMichelle Doose
Michelle Doose
DVDana Verhoeven
Dana Verhoeven
JSJaneth I. Sanchez
Janeth I. Sanchez
JMJennifer K McGee-Avila
Jennifer K McGee-Avila
VCVeronica Chollette
Veronica Chollette
SWSallie J. Weaver
Sallie J. Weaver
PURPOSE: Sixty percent of adults have multiple chronic conditions at cancer diagnosis. These patients may require a multidisciplinary clinical team-of-teams, or a multiteam system (MTS), of high-complexity involving multiple specialists and primary care, who, ideally, coordinate clinical responsibilities, share information, and align clinical decisions to ensure comprehensive care needs are managed. However, insights examining MTS composition and complexity among individuals with cancer and comorbidities at diagnosis using US population-level data are limited. METHODS: Using SEER-Medicare data (2006-2016), we identified newly diagnosed patients with breast, colorectal, or lung cancer who had a codiagnosis of cardiopulmonary disease and/or diabetes (n = 75,201). Zaccaro's theory-based classification of MTSs was used to categorize clinical MTS complexity in the 4 months following cancer diagnosis: high-complexity (≥ 4 clinicians from ≥ 2 specialties) and low-complexity (1-3 clinicians from 1-2 specialties). We describe the proportions of patients with different MTS compositions and quantify the incidence of high-complexity MTS care by patient groups. RESULTS: The most common MTS composition was oncology with primary care (37%). Half (50.3%) received high-complexity MTS care. The incidence of high-complexity MTS care for non-Hispanic Black and Hispanic patients with cancer was 6.7% (95% CI, −8.0 to −5.3) and 4.7% (95% CI, −6.3 to −3.0) lower than non-Hispanic White patients with cancer; 13.1% (95% CI, −14.1 to −12.2) lower for rural residents compared with urban; 10.4% (95% CI, −11.2 to −9.5) lower for dual Medicaid-Medicare beneficiaries compared with Medicare-only; and 16.6% (95% CI, −17.5 to −15.8) lower for colorectal compared with breast cancer. CONCLUSION: Incidence differences of high-complexity MTS care were observed among cancer patients with multiple chronic conditions from underserved populations. The results highlight the need to further understand the effects of and mechanisms through which care team composition, complexity, and functioning affect care quality and outcomes.

1 January 2023 in JCO Oncology Practice
Verified
Journal Article
Closed access
MKMichael P. Kosty
Michael P. Kosty
VCVeronica Chollette
Veronica Chollette
SWSallie J. Weaver
Sallie J. Weaver
JCJohn V. Cox
John V. Cox

8 July 2025 in Public Health Reports®
Verified
Journal Article
Closed access
VCVeronica Y. Chollette
Veronica Y. Chollette
BABlair H. Altman
Blair H. Altman
JMJennifer K. McGee-Avila
Jennifer K. McGee-Avila
EGEmily M. Grenen
Emily M. Grenen
PJPaul B. Jacobsen
Paul B. Jacobsen
SKSarah Kobrin
Sarah Kobrin
Objectives: Supporting medically underserved and socially disadvantaged populations, particularly in relation to cervical cancer, requires identifying coordination gaps. However, approaches to address the cervical cancer screening process between cancer centers and safety-net settings of care (hereinafter, safety-net settings) are poorly understood. We describe interactions and identify opportunities to guide cancer centers that aim to strengthen cervical cancer prevention, screening, and treatment for patients referred to them from safety-net settings. Methods: We administered a 15-item online survey from January 12 through February 9, 2022, to National Cancer Institute (NCI) cancer centers; the intended audience was associate directors of community outreach and engagement and/or associate directors of population sciences. Of 64 eligible cancer centers, 47 (73.4%) completed the survey; however, 7 cancer centers were excluded from analysis because they reported not having a formal arrangement with safety-net settings. We developed survey items in consultation with subject matter experts and conducted pilot testing before administration to sites. Results: The most common forms of partnership between NCI cancer centers and safety-net settings were referrals and consultations (34 of 40; 85.0%). We identified multilevel barriers affecting coordination and follow-up of abnormal cervical cancer screening test results. Communication between safety-net settings and cancer center staff was the most reported systems-level challenge to care coordination (35 of 40; 87.2%). Collection and synthesis of patient data presented the primary systems-level challenge to following up to abnormal cancer screening (34 of 40; 85.0%). Conclusions: Collaborations between cancer centers and safety-net settings are common but limited by challenges in care delivery and coordination. Our findings underscore the importance of identifying intervention points to optimize the management of cervical cancer care for patients in safety-net settings.